VdA advises Lusomedicamenta on two deals

VdA has counselled Lusomedicamenta – Sociedade Técnica Farmacêutica on two sale operations that amounted €31 million

VdA assisted Lusomedicamenta – Sociedade Técnica Farmacêutica S.A., a Portuguese company part of the Recipharm AB group with experience in the pharmaceutical sector, with two transactions totalling €31 million.

The first involved the sale of Lusomedicamenta’s distribution business, represented by its “Medicamenta” business unit focusing on cardiovascular, respiratory and metabolic diseases, to Laboratório Medinfar – Produtos Farmacêuticos, S.A.

The second transaction involved the sale of all shares representing its subsidiary company’s share capital, DAVI II Farmacêutica, S.A., to a private buyer. This was one of the most important deals in the Portuguese pharmaceutical market during 2020, involving two leading market players, with Medinfar having strengthened its market position by acquiring this business unit.

VdA´s team brought together lawyers from its M&A, Health and Labour Law practice areas, namely M&A senior adviser Rita Marques (pictured left), Labour managing associate Tiago Piló (pictured centre), and Health managing associate Pedro Fontes (pictured right), and involved associates Isa Rodrigues, João Francisco Barreiros and Philippa Soares Franco.